Cargando…

Left ventricular assist devices promote changes in the expression levels of platelet microRNAs

INTRODUCTION: MicroRNAs (miRs) emerged as promising diagnostic and therapeutic biomarkers in cardiovascular diseases. The potential clinical utility of platelet miRs in the setting of left ventricular assist device (LVAD) support is unexplored. METHODS: We prospectively measured the expression level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Maria, Bonora, Marta, Baldetti, Luca, Pieri, Marina, Scandroglio, Anna Mara, Landoni, Giovanni, Zangrillo, Alberto, Foglieni, Chiara, Consolo, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308775/ https://www.ncbi.nlm.nih.gov/pubmed/37396581 http://dx.doi.org/10.3389/fcvm.2023.1178556

Ejemplares similares

Clinical characteristics and outcomes of patients with ventricular arrhythmias after continuous‐flow left ventricular assist device implant
por: Gulletta, Simone, et al.
Publicado: (2022)

Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients
por: Lopes, Elisangela C. P., et al.
Publicado: (2022)

Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device
por: Ajmal, Maryam, et al.
Publicado: (2022)

Aortic valve disorders and left ventricular assist devices
por: Acharya, Deepak, et al.
Publicado: (2023)

The Role of Platelet Microparticle Associated microRNAs in Cellular Crosstalk
por: Xia, Luoxing, et al.
Publicado: (2018)

Expression Signatures of Long Noncoding RNAs in Left Ventricular Noncompaction
por: Tian, Qingshan, et al.
Publicado: (2021)

Role of the mitral valve in left ventricular assist device pathophysiology
por: Noly, Pierre-Emmanuel, et al.
Publicado: (2022)

Transcatheter valvular therapies in patients with left ventricular assist devices
por: Dagher, Olina, et al.
Publicado: (2023)

Extubation during extracorporeal membrane oxygenation in severe acute respiratory distress syndrome: time for a paradigm shift?
por: Belletti, Alessandro, et al.
Publicado: (2023)

Reciprocal interferences of the left ventricular assist device and the aortic valve competence
por: Vriz, Olga, et al.
Publicado: (2023)

Physiologic Data-Driven Iterative Learning Control for Left Ventricular Assist Devices
por: Magkoutas, Konstantinos, et al.
Publicado: (2022)

Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices
por: Kortekaas, Kirsten A., et al.
Publicado: (2022)

Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices
por: Dimarakis, Ioannis, et al.
Publicado: (2022)

The role of atria in ventricular fibrillation after continuous-flow left ventricular assist device implantation in ovine model
por: Yu, Xin-Yi, et al.
Publicado: (2023)

A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide
por: Cameli, Matteo, et al.
Publicado: (2022)

Extracorporeal cardiopulmonary resuscitation for out‐of‐hospital cardiac arrest: A systematic review and meta‐analysis of randomized and propensity score‐matched studies
por: Scquizzato, Tommaso, et al.
Publicado: (2022)

Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review
por: Rodenas-Alesina, Eduard, et al.
Publicado: (2022)

Trend and Pattern of 100 Acute Respiratory Distress Syndrome Patients Referred for Venovenous Extracorporeal Membrane Oxygenation Treatment in a National Referral Center in North Italy During the Last Decade
por: Pieri, Marina, et al.
Publicado: (2022)

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom
por: Faldu, Priyansh, et al.
Publicado: (2022)

Right heart failure after left ventricular assist device: From mechanisms to treatments
por: Bravo, Claudio A., et al.
Publicado: (2022)

Key questions about aortic insufficiency in patients with durable left ventricular assist devices
por: Calin, Eliza, et al.
Publicado: (2022)

Editorial: Multimodality imaging of left ventricular assist devices: applications in advanced heart failure
por: Pergola, Valeria, et al.
Publicado: (2023)

A meta-analysis of the diagnostic value of microRNA for hypertensive left ventricular hypertrophy
por: Fei, Su-Hai, et al.
Publicado: (2022)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

The Partial Support of the Left Ventricular Assist Device Shifts the Systemic Cardiac Output Curve Upward in Proportion to the Effective Left Ventricular Ejection Fraction in Pressure-Volume Loop
por: Kakino, Takamori, et al.
Publicado: (2020)

Evaluation of coronary flow is useful in patients with left coronary cusp thrombus formation after left ventricular assist device implantation
por: Sato, Tasuku, et al.
Publicado: (2023)

Predicted Value of MicroRNAs, Vascular Endothelial Growth Factor, and Intermediate Monocytes in the Left Adverse Ventricular Remodeling in Revascularized ST-Segment Elevation Myocardial Infarction Patients
por: Del Toro, Raquel, et al.
Publicado: (2022)

Stroke and pump thrombosis following left ventricular assist device implantation: The impact of the implantation technique
por: Nozdrzykowski, Michal, et al.
Publicado: (2023)

Cardiac mechanics and reverse remodelling under mechanical support from left ventricular assist devices
por: Pamias-Lopez, Blanca, et al.
Publicado: (2023)

Origins of the vagal drive controlling left ventricular contractility
por: Machhada, Asif, et al.
Publicado: (2016)

Diastolic Plateau – Invasive Hemodynamic Marker of Adverse Outcome Among Left Ventricular Assist Device Patients
por: Grupper, Avishay, et al.
Publicado: (2022)

Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests
por: Kranzl, Melanie, et al.
Publicado: (2021)

Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis
por: Wei, Ying, et al.
Publicado: (2023)

Continuous-flow left ventricular assist device treatment for arrhythmogenic right ventricular cardiomyopathy complicated by advanced biventricular failure – University of Tokyo experiences
por: Ono, Minoru
Publicado: (2022)

Blood flow kinetic energy is a novel marker for right ventricular global systolic function in patients with left ventricular assist device therapy
por: Akiyama, Koichi, et al.
Publicado: (2023)

Different Expressions of Pericardial Fluid MicroRNAs in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Ischemic Heart Disease Undergoing Ventricular Tachycardia Ablation
por: Khudiakov, Aleksandr A., et al.
Publicado: (2021)

Eleven Years of Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: From H1N1 to SARS-CoV-2. Experience and Perspectives of a National Referral Center
por: Pieri, Marina, et al.
Publicado: (2022)

Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography
por: Demirozu, Zumrut Tuba, et al.
Publicado: (2016)

A Sensorless Modular Multiobjective Control Algorithm for Left Ventricular Assist Devices: A Clinical Pilot Study
por: Maw, Martin, et al.
Publicado: (2022)

Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
por: Abdelshafy, Mahmoud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48gkh3e4ql6aadpp3oaa2296t1